Publications


Ph.D. thesis

mail icon Q. Klopfenstein, Non-smooth optimization for the estimation of cellular immune components in a tumoral environment . Defended on June, 30th, 2021. Manuscript, Slides.


Mathematics and Machine Learning

Publications

mail icon Q. Bertrand, QK, M. Blondel, S. Vaiter, A. Gramfort, J. Salmon. Implicit differentiation of Lasso-type models for hyperparameter optimization. Internation Conference on Machine Learning, 2020

mail icon QK, Samuel Vaiter. Linear Support Vector Regression with Linear Constraints. Accepter for publication. Mach Learn., 39 pages. 2021

Preprints

mail icon Q. Bertrand, QK, M. Massias, M. Blondel, S. Vaiter, A. Gramfort, J. Salmon. Implicit differentiation for fast hyperparameter selection in non-smooth convex learning. Submitted. arXiv:2105.01637. 45 pages. 2021

mail icon QK, Q. Bertrand, A. Gramfort, J. Salmon, S. Vaiter. Model identification and local linear convergence of coordinate descent. Submitted. arXiv:2010.11825. 26 pages. 2020


Biostatistics

mail icon QK, V. Derangère, L. Arnould, M. Thibaudin et al. Evaluation of tumor immune contexture among intrinsic molecular subtypes helps to predict outcome in early breast cancer. JITC, 2021

mail icon C. Reichling, J. Taieb, V. Derangère, QK et al. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study. Gut, 2019

mail icon QK, C. Truntzer, J. Vincent, F. Ghiringhelli. Cell lines and immune classification of glioblastoma define patient’s prognosis. British Journal of Cancer, 2019

mail icon F. Ledys, QK, C. Truntzer, L. Arnould et al. RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer. JITC, 2018

mail icon JD. Fumet, C. Richard, F. Ledys, QK, et al. Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy. British Journal of Cancer, 2018

mail icon T. Collot, JD. Fumet, QK, J. Vincent et al. Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors. Anticancer Research, 2018